Chenguang Biotech Group Co Ltd
SZSE:300138
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.09
14.99
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Chenguang Biotech Group Co Ltd
Income from Continuing Operations
Chenguang Biotech Group Co Ltd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Chenguang Biotech Group Co Ltd
SZSE:300138
|
Income from Continuing Operations
ÂĄ344m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
20%
|
|
|
Inner Mongolia Yili Industrial Group Co Ltd
SSE:600887
|
Income from Continuing Operations
ÂĄ8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
Income from Continuing Operations
ÂĄ6.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
|
|
Yihai Kerry Arawana Holdings Co Ltd
SZSE:300999
|
Income from Continuing Operations
ÂĄ2.5B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Muyuan Foods Co Ltd
SZSE:002714
|
Income from Continuing Operations
ÂĄ22.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-4%
|
CAGR 10-Years
52%
|
|
|
Wens Foodstuff Group Co Ltd
SZSE:300498
|
Income from Continuing Operations
ÂĄ8.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Chenguang Biotech Group Co Ltd
Glance View
Chenguang Biotech Group Co., Ltd. engages in natural plant extractions. The company is headquartered in Handan, Hebei and currently employs 1,757 full-time employees. The company went IPO on 2010-11-05. The Company’s products include pigment, spices, supplement and medicine products, cottonseed products and others. The firm distributes its products in domestic and to overseas markets.
See Also
What is Chenguang Biotech Group Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
344m
CNY
Based on the financial report for Sep 30, 2025, Chenguang Biotech Group Co Ltd's Income from Continuing Operations amounts to 344m CNY.
What is Chenguang Biotech Group Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
20%
Over the last year, the Income from Continuing Operations growth was 179%. The average annual Income from Continuing Operations growth rates for Chenguang Biotech Group Co Ltd have been -7% over the past three years , 7% over the past five years , and 20% over the past ten years .